⌘K

Home/Filings/4/0001144204-19-031921

4//SEC Filing

Zhou Quan 4

Accession 0001144204-19-031921

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:01 PM ET

Size

5.4 KB

Accession

0001144204-19-031921

Insider Transaction Report

Form 4

Period: 2019-06-20

CASI Pharmaceuticals, Inc.CASI

Director10% Owner

Transactions

Award
Stock Option (Right to Buy)
2019-06-20+56,731→ 56,731 total
Exercise: $3.13Exp: 2029-06-20→ Common Stock (56,731 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

1 file

4
tv524059_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001491503

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 5:01 PM ET
Size: 5.4 KB

View on SEC.gov